Gabet Amélie, Béjot Yannick, Touzé Emmanuel, Woimant France, Suissa Laurent, Grave Clémence, Lailler Grégory, Tuppin Philippe, Olié Valérie
Santé Publique France, 94410 Saint-Maurice, France.
Dijon Stroke Registry, Unit EA7460, Cardiocerebrovascular Pathophysiology and Epidemiology (PEC2), University of Burgundy, 21000 Dijon, France; Department of Neurology, Dijon University Hospital, 21000 Dijon, France.
Arch Cardiovasc Dis. 2024 Dec;117(12):682-692. doi: 10.1016/j.acvd.2024.10.327. Epub 2024 Nov 22.
It has been nearly 10years since the first national stroke plan in France.
To examine the epidemiology of strokes, how they are managed and patient outcomes.
Adults hospitalized for stroke in 2022 were identified in the national database. Stroke prevalence at 1 January 2023 was defined as the number of people alive at that date with a history of hospitalization for stroke or a chronic long-term disease status due to stroke (2012-2022). Patients were monitored up for up to 1year after hospitalization for a stroke.
In 2022, 122,422 adults were hospitalized due to stroke, and there were an estimated 1,086,795 cases. Important geographical and socioeconomic disparities were observed. Admission to a stroke intensive care unit was found in 46.8% of patients, with significant variations by department of residence, age and gender. Only 7.2% of ischaemic strokes resulted in mechanical thrombectomy. Among survivors at 6months, admission to a rehabilitation unit was found for 34.3% for patients with ischaemic strokes and 41.7% of those with haemorrhagic strokes, while 28.8% and 18.8%, respectively, had a consultation with a neurologist, and 19.5% and 10.9% were seen by a cardiologist within 6months. Mortality rates after 1year were 20.8% and 37.9% among patients hospitalized due to ischaemic and haemorrhagic strokes, respectively.
The considerable numbers and rates of stroke - and disparities by age, sex and area - highlight the need for more effective stroke prevention, regular information campaigns on the symptoms of stroke and improved availability and accessibility of stroke units.
法国首个全国性卒中计划实施至今已近10年。
研究卒中的流行病学、治疗方式及患者预后。
在国家数据库中识别出2022年因卒中住院的成年人。2023年1月1日的卒中患病率定义为当日存活的有卒中住院史或因卒中导致慢性长期疾病状态的人数（2012 - 2022年）。对卒中住院患者进行长达1年的随访。
2022年，122,422名成年人因卒中住院，估计病例数为1,086,795例。观察到重要的地理和社会经济差异。46.8%的患者入住了卒中重症监护病房，按居住部门、年龄和性别存在显著差异。仅7.2%的缺血性卒中接受了机械取栓治疗。在6个月时的幸存者中，缺血性卒中患者有34.3%入住康复病房，出血性卒中患者有41.7%入住康复病房，而分别有28.8%和18.8%的患者在6个月内咨询了神经科医生，19.5%和10.9%的患者在6个月内看了心脏病专家。缺血性卒中和出血性卒中住院患者1年后的死亡率分别为20.8%和37.9%。
卒中的数量和发生率之高，以及年龄、性别和地区差异，凸显了更有效的卒中预防、定期开展卒中症状宣传活动以及改善卒中单元的可及性和可获得性的必要性。
